Athyrium Opportunities IV Acquisition 2 LP - Insider Trading & Ownership

Entity
Company
Location
505 Fifth Avenue, Floor 18, New York, NY
Summary
The estimated value of insider holdings of Athyrium Opportunities IV Acquisition 2 LP is at least $201K dollars as of August 12, 2022. Athyrium Opportunities IV Acquisition 2 LP is the 10%+ Owner of RVL Pharmaceuticals plc and owns shares of RVL Pharmaceuticals plc (RVLPQ) stock worth about $201K.
All Insider Reports
All Insider Reports

Ownership of Athyrium Opportunities IV Acquisition 2 LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RVLPQ RVL Pharmaceuticals plc 10%+ Owner $201K Aug 8, 2022

There are no insider transactions reported by Athyrium Opportunities IV Acquisition 2 LP